Family Medicine Doctors in Mineola, TX Accepting Medicare
5 Family Medicine doctors found. Showing 1 - 5
 Roel O Flores Jr., DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1302 N Pacific St, Mineola, TX 75773 Phone: 903-569-5383 |
 Dr. Diana Bankhead, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 139 Maxine St, Mineola, TX 75773 Phone: 903-569-2929 Fax: 903-569-2938 |
Dr. Craig Mcmullen, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1220 N Pacific St, Mineola, TX 75773 Phone: 903-569-6124 Fax: 903-567-2467 |
Dr. Robert M Elliott, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 415 W Kilpatrick St, Mineola, TX 75773 Phone: 903-569-2006 Fax: 903-567-2206 |
Kyle L Gully, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1302 N Pacific St, Mineola, TX 75773 Phone: 903-569-5383 |
News Archive
SecureWorks cited leader in managed security services by Forrester
Atlanta-based SecureWorks®, Inc., a leading global provider of security services protecting 2,900 clients worldwide, announced today that the company was one of only two "leaders" cited in The Forrester Wave™: Managed Security Services, Q3 2010 report (August 2010). SecureWorks was among 11 select Managed Security Services (MSS) providers that Forrester Research, Inc. invited to participate in the study.
Opioid naive individuals at low risk of developing persistent opioid use after surgery, research shows
Researchers from the University Health Network's Department of Anesthesia and Pain Management and the Institute for Clinical Evaluative Sciences have determined that patients who have not had an opioid prescription within a year prior to their procedure are at low risk of developing persistent opioid use after major surgery.
Positive results from trial of investigational anti-epilepsy drug Brivaracetam
UCB has announced data demonstrating that anti-epileptic drug (AED) brivaracetam, with the proposed trade name Rikelta, administered as an adjunctive treatment in adults with refractory epilepsy with partial onset seizures, significantly reduced seizure frequency and had a side-effect profile comparable to placebo.
TSRI scientists design artificial proteins as a candidate vaccine against RSV
Scientists at The Scripps Research Institute (TSRI) have invented a new method for designing artificial proteins, and have used it to make key ingredients for a candidate vaccine against a dangerous virus, respiratory syncytial virus (RSV), a significant cause of infant mortality.
› Verified 4 days ago